Biography
Dr. Lee Krug is a medical oncologist at Memorial Sloan Kettering Cancer Center who has been at the forefront of mesothelioma immunotherapy research for over two decades. He led pioneering clinical trials of the WT1 peptide vaccine for mesothelioma and has been involved in testing numerous novel immunotherapy combinations. Dr. Krug is one of the most recognized names in mesothelioma medical oncology worldwide.
Education & Training
- Medical Degree — Cornell University Medical College (Medicine)
- Residency — NewYork-Presbyterian Hospital (Internal Medicine)
- Fellowship — Memorial Sloan Kettering Cancer Center (Medical Oncology)
Specialties & Procedures
Clinical Specialties
- Medical Oncology
- Thoracic Oncology
- Mesothelioma
As a medical oncologist, Dr. Lee Krug focuses on non-surgical treatment modalities including chemotherapy, immunotherapy, targeted therapy, and clinical trials.
Board Certifications
- American Board of Internal Medicine — Medical Oncology
- American Board of Internal Medicine — Internal Medicine
Research Focus
Immunotherapy for mesothelioma, vaccine-based approaches, WT1 peptide vaccine clinical trials, and novel combination therapies for pleural malignancies.
Notable Publications
- WT1 peptide vaccine for malignant pleural mesothelioma. Journal of Clinical Oncology, 2010.
Treatment Center
Dr. Lee Krug practices at Memorial Sloan Kettering Cancer Center in New York, NY.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
What is the WT1 vaccine for mesothelioma?
The WT1 peptide vaccine is a cancer vaccine designed to stimulate the immune system to attack cells expressing the WT1 protein, which is commonly found on mesothelioma cells. Dr. Krug led clinical trials of this approach at Memorial Sloan Kettering.
Is Dr. Krug currently seeing mesothelioma patients?
Yes. Dr. Krug is an active member of the thoracic oncology service at Memorial Sloan Kettering and continues to treat mesothelioma patients and lead clinical trials.